ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Edoxaban Tosilate Orally Disintegrating Tablets Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-24L14551
Home | Market Reports | Computers & Electronics
Global Edoxaban Tosilate Orally Disintegrating Tablets Market Research Report 2023
BUY CHAPTERS

Global Edoxaban Tosilate Orally Disintegrating Tablets Market Research Report 2025

Code: QYRE-Auto-24L14551
Report
May 2025
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Daiichi Sankyo
Menarini Group
Simcere Pharmaceutical
Lunan Pharmaceutical Group

Edoxaban Tosilate Orally Disintegrating Tablets Market Size

The global market for Edoxaban Tosilate Orally Disintegrating Tablets was valued at US$ 1828 million in the year 2024 and is projected to reach a revised size of US$ 3998 million by 2031, growing at a CAGR of 12.0% during the forecast period.

Edoxaban Tosilate Orally Disintegrating Tablets Market

Edoxaban Tosilate Orally Disintegrating Tablets Market

Edoxaban Tosilate Orally Disintegrating Tablets are a type of anticoagulant medication designed to prevent and treat conditions related to blood clots, such as deep vein thrombosis, pulmonary embolism, and stroke prevention in patients with non-valvular atrial fibrillation. The active ingredient, edoxaban, is a direct Factor Xa inhibitor, which works by interrupting the blood clotting cascade and reducing the risk of clot formation. These tablets are formulated to disintegrate quickly in the mouth without the need for water, making them particularly convenient for patients who have difficulty swallowing traditional tablets. This delivery method ensures ease of administration while maintaining therapeutic efficacy.
The market for Edoxaban Tosilate Orally Disintegrating Tablets is driven by the rising prevalence of thromboembolic disorders, such as deep vein thrombosis, pulmonary embolism, and stroke associated with atrial fibrillation. With increasing awareness of the importance of anticoagulation therapy and the growing geriatric population at higher risk of clotting disorders, demand for user-friendly and effective anticoagulant formulations has surged. Orally disintegrating tablets, offering enhanced patient compliance due to their convenience and ease of administration, particularly benefit individuals with swallowing difficulties. Market growth is further supported by advancements in drug delivery technologies and the expansion of healthcare access in emerging economies. However, challenges such as high treatment costs, potential bleeding risks, and competition from alternative anticoagulants may restrain growth. Regulatory approvals and strategic collaborations among pharmaceutical companies are expected to play a key role in shaping the market's trajectory.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Edoxaban Tosilate Orally Disintegrating Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Edoxaban Tosilate Orally Disintegrating Tablets.
The Edoxaban Tosilate Orally Disintegrating Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Edoxaban Tosilate Orally Disintegrating Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Edoxaban Tosilate Orally Disintegrating Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Edoxaban Tosilate Orally Disintegrating Tablets Market Report

Report Metric Details
Report Name Edoxaban Tosilate Orally Disintegrating Tablets Market
Accounted market size in year US$ 1828 million
Forecasted market size in 2031 US$ 3998 million
CAGR 12.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 30 mg
  • 60 mg
  • Other
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Daiichi Sankyo, Menarini Group, Simcere Pharmaceutical, Lunan Pharmaceutical Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Edoxaban Tosilate Orally Disintegrating Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Edoxaban Tosilate Orally Disintegrating Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Edoxaban Tosilate Orally Disintegrating Tablets Market growing?

Ans: The Edoxaban Tosilate Orally Disintegrating Tablets Market witnessing a CAGR of 12.0% during the forecast period 2025-2031.

What is the Edoxaban Tosilate Orally Disintegrating Tablets Market size in 2031?

Ans: The Edoxaban Tosilate Orally Disintegrating Tablets Market size in 2031 will be US$ 3998 million.

Who are the main players in the Edoxaban Tosilate Orally Disintegrating Tablets Market report?

Ans: The main players in the Edoxaban Tosilate Orally Disintegrating Tablets Market are Daiichi Sankyo, Menarini Group, Simcere Pharmaceutical, Lunan Pharmaceutical Group

What are the Application segmentation covered in the Edoxaban Tosilate Orally Disintegrating Tablets Market report?

Ans: The Applications covered in the Edoxaban Tosilate Orally Disintegrating Tablets Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Edoxaban Tosilate Orally Disintegrating Tablets Market report?

Ans: The Types covered in the Edoxaban Tosilate Orally Disintegrating Tablets Market report are 30 mg, 60 mg, Other

Recommended Reports

Anticoagulant Drugs

Orally Disintegrating Tablets

Thromboembolism & Thrombosis

1 Edoxaban Tosilate Orally Disintegrating Tablets Market Overview
1.1 Product Definition
1.2 Edoxaban Tosilate Orally Disintegrating Tablets by Type
1.2.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Market Value Comparison by Type (2024 VS 2031)
1.2.2 30 mg
1.2.3 60 mg
1.2.4 Other
1.3 Edoxaban Tosilate Orally Disintegrating Tablets by Application
1.3.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Edoxaban Tosilate Orally Disintegrating Tablets Market Size Estimates and Forecasts
1.4.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue 2020-2031
1.4.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Sales 2020-2031
1.4.3 Global Edoxaban Tosilate Orally Disintegrating Tablets Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Edoxaban Tosilate Orally Disintegrating Tablets Market Competition by Manufacturers
2.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Edoxaban Tosilate Orally Disintegrating Tablets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Edoxaban Tosilate Orally Disintegrating Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Edoxaban Tosilate Orally Disintegrating Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Edoxaban Tosilate Orally Disintegrating Tablets, Product Type & Application
2.7 Global Key Manufacturers of Edoxaban Tosilate Orally Disintegrating Tablets, Date of Enter into This Industry
2.8 Global Edoxaban Tosilate Orally Disintegrating Tablets Market Competitive Situation and Trends
2.8.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Edoxaban Tosilate Orally Disintegrating Tablets Players Market Share by Revenue
2.8.3 Global Edoxaban Tosilate Orally Disintegrating Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Edoxaban Tosilate Orally Disintegrating Tablets Market Scenario by Region
3.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Sales by Region: 2020-2031
3.2.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Sales by Region: 2020-2025
3.2.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Sales by Region: 2026-2031
3.3 Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Region: 2020-2031
3.3.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Region: 2020-2025
3.3.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Region: 2026-2031
3.4 North America Edoxaban Tosilate Orally Disintegrating Tablets Market Facts & Figures by Country
3.4.1 North America Edoxaban Tosilate Orally Disintegrating Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Edoxaban Tosilate Orally Disintegrating Tablets Sales by Country (2020-2031)
3.4.3 North America Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Edoxaban Tosilate Orally Disintegrating Tablets Market Facts & Figures by Country
3.5.1 Europe Edoxaban Tosilate Orally Disintegrating Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales by Country (2020-2031)
3.5.3 Europe Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Edoxaban Tosilate Orally Disintegrating Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Edoxaban Tosilate Orally Disintegrating Tablets Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Edoxaban Tosilate Orally Disintegrating Tablets Sales by Region (2020-2031)
3.6.3 Asia Pacific Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Edoxaban Tosilate Orally Disintegrating Tablets Market Facts & Figures by Country
3.7.1 Latin America Edoxaban Tosilate Orally Disintegrating Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Edoxaban Tosilate Orally Disintegrating Tablets Sales by Country (2020-2031)
3.7.3 Latin America Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Edoxaban Tosilate Orally Disintegrating Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Edoxaban Tosilate Orally Disintegrating Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Sales by Type (2020-2031)
4.1.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Sales by Type (2020-2025)
4.1.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Sales by Type (2026-2031)
4.1.3 Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Type (2020-2031)
4.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Type (2020-2031)
4.2.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Type (2020-2025)
4.2.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Type (2026-2031)
4.2.3 Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Type (2020-2031)
4.3 Global Edoxaban Tosilate Orally Disintegrating Tablets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Sales by Application (2020-2031)
5.1.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Sales by Application (2020-2025)
5.1.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Sales by Application (2026-2031)
5.1.3 Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Application (2020-2031)
5.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Application (2020-2031)
5.2.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Application (2020-2025)
5.2.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Application (2026-2031)
5.2.3 Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Application (2020-2031)
5.3 Global Edoxaban Tosilate Orally Disintegrating Tablets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Daiichi Sankyo
6.1.1 Daiichi Sankyo Company Information
6.1.2 Daiichi Sankyo Description and Business Overview
6.1.3 Daiichi Sankyo Edoxaban Tosilate Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Daiichi Sankyo Edoxaban Tosilate Orally Disintegrating Tablets Product Portfolio
6.1.5 Daiichi Sankyo Recent Developments/Updates
6.2 Menarini Group
6.2.1 Menarini Group Company Information
6.2.2 Menarini Group Description and Business Overview
6.2.3 Menarini Group Edoxaban Tosilate Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Menarini Group Edoxaban Tosilate Orally Disintegrating Tablets Product Portfolio
6.2.5 Menarini Group Recent Developments/Updates
6.3 Simcere Pharmaceutical
6.3.1 Simcere Pharmaceutical Company Information
6.3.2 Simcere Pharmaceutical Description and Business Overview
6.3.3 Simcere Pharmaceutical Edoxaban Tosilate Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Simcere Pharmaceutical Edoxaban Tosilate Orally Disintegrating Tablets Product Portfolio
6.3.5 Simcere Pharmaceutical Recent Developments/Updates
6.4 Lunan Pharmaceutical Group
6.4.1 Lunan Pharmaceutical Group Company Information
6.4.2 Lunan Pharmaceutical Group Description and Business Overview
6.4.3 Lunan Pharmaceutical Group Edoxaban Tosilate Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Lunan Pharmaceutical Group Edoxaban Tosilate Orally Disintegrating Tablets Product Portfolio
6.4.5 Lunan Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Edoxaban Tosilate Orally Disintegrating Tablets Industry Chain Analysis
7.2 Edoxaban Tosilate Orally Disintegrating Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Edoxaban Tosilate Orally Disintegrating Tablets Production Mode & Process Analysis
7.4 Edoxaban Tosilate Orally Disintegrating Tablets Sales and Marketing
7.4.1 Edoxaban Tosilate Orally Disintegrating Tablets Sales Channels
7.4.2 Edoxaban Tosilate Orally Disintegrating Tablets Distributors
7.5 Edoxaban Tosilate Orally Disintegrating Tablets Customer Analysis
8 Edoxaban Tosilate Orally Disintegrating Tablets Market Dynamics
8.1 Edoxaban Tosilate Orally Disintegrating Tablets Industry Trends
8.2 Edoxaban Tosilate Orally Disintegrating Tablets Market Drivers
8.3 Edoxaban Tosilate Orally Disintegrating Tablets Market Challenges
8.4 Edoxaban Tosilate Orally Disintegrating Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Daiichi Sankyo
Menarini Group
Simcere Pharmaceutical
Lunan Pharmaceutical Group
List of Tables
 Table 1. Global Edoxaban Tosilate Orally Disintegrating Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Edoxaban Tosilate Orally Disintegrating Tablets Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Edoxaban Tosilate Orally Disintegrating Tablets Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Edoxaban Tosilate Orally Disintegrating Tablets Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Edoxaban Tosilate Orally Disintegrating Tablets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Edoxaban Tosilate Orally Disintegrating Tablets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Edoxaban Tosilate Orally Disintegrating Tablets, Product Type & Application
 Table 12. Global Key Manufacturers of Edoxaban Tosilate Orally Disintegrating Tablets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Edoxaban Tosilate Orally Disintegrating Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Edoxaban Tosilate Orally Disintegrating Tablets as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Edoxaban Tosilate Orally Disintegrating Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales by Region (2020-2025) & (K Units)
 Table 18. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Region (2020-2025)
 Table 19. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales by Region (2026-2031) & (K Units)
 Table 20. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Region (2026-2031)
 Table 21. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Region (2020-2025)
 Table 23. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Region (2026-2031)
 Table 25. North America Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Edoxaban Tosilate Orally Disintegrating Tablets Sales by Country (2020-2025) & (K Units)
 Table 27. North America Edoxaban Tosilate Orally Disintegrating Tablets Sales by Country (2026-2031) & (K Units)
 Table 28. North America Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Edoxaban Tosilate Orally Disintegrating Tablets Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Edoxaban Tosilate Orally Disintegrating Tablets Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Edoxaban Tosilate Orally Disintegrating Tablets Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Edoxaban Tosilate Orally Disintegrating Tablets Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales (K Units) by Type (2020-2025)
 Table 51. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales (K Units) by Type (2026-2031)
 Table 52. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Type (2020-2025)
 Table 53. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Type (2026-2031)
 Table 54. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Type (2020-2025)
 Table 57. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Type (2026-2031)
 Table 58. Global Edoxaban Tosilate Orally Disintegrating Tablets Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Edoxaban Tosilate Orally Disintegrating Tablets Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales (K Units) by Application (2020-2025)
 Table 61. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales (K Units) by Application (2026-2031)
 Table 62. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Application (2020-2025)
 Table 63. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Application (2026-2031)
 Table 64. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Application (2020-2025)
 Table 67. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Application (2026-2031)
 Table 68. Global Edoxaban Tosilate Orally Disintegrating Tablets Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Edoxaban Tosilate Orally Disintegrating Tablets Price (US$/Unit) by Application (2026-2031)
 Table 70. Daiichi Sankyo Company Information
 Table 71. Daiichi Sankyo Description and Business Overview
 Table 72. Daiichi Sankyo Edoxaban Tosilate Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Daiichi Sankyo Edoxaban Tosilate Orally Disintegrating Tablets Product
 Table 74. Daiichi Sankyo Recent Developments/Updates
 Table 75. Menarini Group Company Information
 Table 76. Menarini Group Description and Business Overview
 Table 77. Menarini Group Edoxaban Tosilate Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Menarini Group Edoxaban Tosilate Orally Disintegrating Tablets Product
 Table 79. Menarini Group Recent Developments/Updates
 Table 80. Simcere Pharmaceutical Company Information
 Table 81. Simcere Pharmaceutical Description and Business Overview
 Table 82. Simcere Pharmaceutical Edoxaban Tosilate Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Simcere Pharmaceutical Edoxaban Tosilate Orally Disintegrating Tablets Product
 Table 84. Simcere Pharmaceutical Recent Developments/Updates
 Table 85. Lunan Pharmaceutical Group Company Information
 Table 86. Lunan Pharmaceutical Group Description and Business Overview
 Table 87. Lunan Pharmaceutical Group Edoxaban Tosilate Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Lunan Pharmaceutical Group Edoxaban Tosilate Orally Disintegrating Tablets Product
 Table 89. Lunan Pharmaceutical Group Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. Edoxaban Tosilate Orally Disintegrating Tablets Distributors List
 Table 93. Edoxaban Tosilate Orally Disintegrating Tablets Customers List
 Table 94. Edoxaban Tosilate Orally Disintegrating Tablets Market Trends
 Table 95. Edoxaban Tosilate Orally Disintegrating Tablets Market Drivers
 Table 96. Edoxaban Tosilate Orally Disintegrating Tablets Market Challenges
 Table 97. Edoxaban Tosilate Orally Disintegrating Tablets Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Edoxaban Tosilate Orally Disintegrating Tablets
 Figure 2. Global Edoxaban Tosilate Orally Disintegrating Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Edoxaban Tosilate Orally Disintegrating Tablets Market Share by Type: 2024 & 2031
 Figure 4. 30 mg Product Picture
 Figure 5. 60 mg Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Edoxaban Tosilate Orally Disintegrating Tablets Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Edoxaban Tosilate Orally Disintegrating Tablets Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Other
 Figure 12. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Edoxaban Tosilate Orally Disintegrating Tablets Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales (2020-2031) & (K Units)
 Figure 15. Global Edoxaban Tosilate Orally Disintegrating Tablets Average Price (US$/Unit) & (2020-2031)
 Figure 16. Edoxaban Tosilate Orally Disintegrating Tablets Report Years Considered
 Figure 17. Edoxaban Tosilate Orally Disintegrating Tablets Sales Share by Manufacturers in 2024
 Figure 18. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Edoxaban Tosilate Orally Disintegrating Tablets Players: Market Share by Revenue in Edoxaban Tosilate Orally Disintegrating Tablets in 2024
 Figure 20. Edoxaban Tosilate Orally Disintegrating Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Edoxaban Tosilate Orally Disintegrating Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Country (2020-2031)
 Figure 23. North America Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Country (2020-2031)
 Figure 24. United States Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Country (2020-2031)
 Figure 27. Europe Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Region (2020-2031)
 Figure 35. China Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Edoxaban Tosilate Orally Disintegrating Tablets by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Edoxaban Tosilate Orally Disintegrating Tablets by Type (2020-2031)
 Figure 54. Global Edoxaban Tosilate Orally Disintegrating Tablets Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Edoxaban Tosilate Orally Disintegrating Tablets by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Edoxaban Tosilate Orally Disintegrating Tablets by Application (2020-2031)
 Figure 57. Global Edoxaban Tosilate Orally Disintegrating Tablets Price (US$/Unit) by Application (2020-2031)
 Figure 58. Edoxaban Tosilate Orally Disintegrating Tablets Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Edoxaban Tosilate Tablets and Generic Drugs Market Research Report 2024
Global Oral Factor Xa Inhibitors Market Research Report 2024
Global Edoxaban API Market Research Report 2024
Global Edoxaban Reagent Market Research Report 2024
Global Direct Oral Anticoagulants DOACs Market Research Report 2024
Global Dabigatran Etexilate Mesylate Market Research Report 2024
Global Rivaroxaban Drugs Market Research Report 2024
Global Direct Oral Anticoagulant Market Insights Forecast to 2030
Global Freeze Dried Orally Disintegrating Tablets Market Research Report 2024
Global Orally Disintegrating Tablet Excipient Market Insights Forecast to 2030
Global Orally Disintegrating Tablets ODT Platform Market Research Report 2024
Edoxaban Tosylate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dabigatran Etexilate Capsules Market Research Report 2024
Global Dabigatran Etexilate Drugs Market Research Report 2024
Global Galantamine Hydrobromide Orally Disintegrating Tablets Market Research Report 2025
Global Rivaroxaban Tablets Market Research Report 2024
Global Orally Disintegrating Tablet Technology Market Research Report 2024
Global FXa Inhibitor Market Research Report 2025
Global Orally Disintegrating Tablets Market Research Report 2024
Global Oral Anticoagulants Market Research Report 2024

RELATED REPORTS

Global Big Data Spending in Healthcare Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5E6179
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global BYOD Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11T6229
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Translation Management Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36Z5964
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Archiving Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11S6221
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions